Jefferies Financial Group’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-53,700
Closed -$980K 1953
2025
Q3
$980K Sell
53,700
-683
-1% -$13.3K ﹤0.01% 880
2025
Q2
$1.09M Buy
54,383
+43,945
+421% +$845K 0.01% 711
2025
Q1
$189K Sell
10,438
-285,800
-96% -$5.12M ﹤0.01% 1400
2024
Q4
$5.14M Buy
296,238
+231,238
+356% +$4.44M 0.03% 355
2024
Q3
$1.26M Buy
+65,000
New +$1.2M 0.01% 726
2024
Q2
Sell
-48,000
Closed -$732K 1619
2024
Q1
$732K Buy
48,000
+11,000
+30% +$173K 0.01% 934
2023
Q4
$593K Buy
+37,000
New +$517K ﹤0.01% 1154

Other funds holding INVA

Jefferies Financial Group's INVA Position: Q4 2025 in Review

Jefferies Financial Group sold out of Innoviva (INVA) in Q4 2025, closing a stake of 53,700 shares — an estimated $980K sold.

Jefferies Financial Group first reported a position in INVA in Q4 2023 and held it in 7 quarters. The position peaked at $5.14M in Q4 2024. 280 funds tracked by Wall St. Rank hold INVA as of Q4 2025.

  • Jefferies Financial Group reported no remaining Innoviva position as of Q4 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 53,700 Innoviva shares in Q4 2025, an estimated $980K.
  • Jefferies Financial Group first reported a position in Innoviva in Q4 2023 and held it in 7 quarters.
  • Jefferies Financial Group's Innoviva position peaked at $5.14M in Q4 2024.
  • 280 funds tracked by Wall St. Rank held Innoviva as of Q4 2025.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.